David Ricks; Chairman of the Board, President, Chief Executive Officer; Eli Lilly and Co Lucas Montarce; Executive Vice President and Chief Financial Officer; Eli Lilly and Co Daniel Skovronsky ...

David Ricks; Chairman of the Board, President, Chief Executive Officer; Eli Lilly and Co Lucas Montarce; Executive Vice President and Chief Financial Officer; Eli Lilly and Co Daniel Skovronsky; Chief ...

Thank you for joining us for Eli Lilly and Company's Q4 2024 ... chief scientific officer and president of Lilly Immunology; Lucas Montarce, chief financial officer; Anne White, president of ...

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company's quarterly earnings topped ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...

Good morning, thank you for joining us for Eli Lilly and Company's Q4 2024 ... Chief Scientific Officer and President of Lilly Immunology; Lucas Montarce, Chief Financial Officer; Anne White ...

"so that's what we built in our 2025 guidance for the market," the company's CFO Lucas Montarce said during an earnings call on Thursday. Shares of Eli Lilly rose more than 4% on Thursday.